Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03652636 · ClinicalTrials.gov registry record · Phase 4
Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic Lesions
A Phase 4 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 4
- Development phase
- 47
- Enrollment target
NCT03652636 is a Phase 4 study that has completed, run by Indiana University. The registered enrollment target is 47 participants.
The verdict
NCT03652636, a Phase 4 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 47 participants
- Enrollment target
Study Summary
In patients with hepatic lesions, to evaluate the efficacy of contrast enhanced ultrasound compared to MRI in differentiating focal nodular hyperplasia and hepatic adenoma.
Interventions
- DRUG Sulfur Hexafluoride Microspheres
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2019-08-05 |
| Est. Completion | 2023-07-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03652636
The ClinicalTrials.gov registry entry for NCT03652636 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sulfur Hexafluoride Microspheres is the first listed.
NCT03652636 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03652636 about?
NCT03652636 is a clinical study titled "Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic Lesions". In patients with hepatic lesions, to evaluate the efficacy of contrast enhanced ultrasound compared to MRI in differentiating focal nodular hyperplasia and hepatic adenoma.
What is the current status of trial NCT03652636?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 47 participants. The study started on 2019-08-05. Estimated completion is 2023-07-21.
What interventions are being tested in trial NCT03652636?
The interventions under investigation include: Sulfur Hexafluoride Microspheres (DRUG).
Who is sponsoring clinical trial NCT03652636?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.